Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER

No-Receipt date 2021-03719 - 28/09/2021
No-Filing date 20210402576 - 28/09/2021
No-Granting date 3108508 - 01/10/2021
No-EPO application date 15715805.6 - 02/04/2015
No-EPO granting date 3125885 - 30/06/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2021 - 11/11/2021
Expiration date 03/04/2035
Kind of title Validation of European Patent
Legal status VALID
Priorities US201461975088 P04/04/2014/US
US201462013573 P18/06/2014/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 35/00
A61K 31/5377
A61K 31/506
A61K 31/4184

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1338582 ASTRAZENECA AB .151 85 SODERTALJE SWEDEN

Inventors
CodeFirstnameSurname
3434782 CROSS, DARREN ANTHONY EDWARD
3434783 EBERLEIN, CATHERINE ANNE

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 11 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015